Teste PSA (Prostate Specific Antigen) e sua importância na prevenção do câncer de próstata: Um estudo com a população masculina no município de Trindade – Goiás

Abstract

Prostate cancer ranks second among malignant neoplasms that affect men worldwide, second only to lung cancer. According to the National Cancer Institute (INCA) in Brazil, there were around 61,200 new cases of prostate cancer in Brazil in 2016. By 2018, an incidence of 68,220 cases is estimated, corresponding to a risk of 66.12 new cases every 100,000 men in the country. Mortality from prostate cancer has declined in the last decade, attributed by many to the widespread use of prostate-specific antigen-based (PSA) detection strategies. Screening for prostate cancer using PSA is widely used in the general population, contributing to a three-fold increase in the incidence of diagnosed prostate cancer. The objective of this study is to evaluate the population 's understanding of the importance of the Prostatic Specific Antigen (PSA) test in the prevention of prostate cancer and the reasons for the adherence or not of male individuals from a municipal body in the municipality of Trindade - Goiás to this test. An exploratory and descriptive field research was carried out following a qualitative approach. The study was carried out with 16 male individuals from a municipal body in the city of Trindade - Goiás. It is necessary to use human health policies as guiding the assistance, enabling multiprofessional strategies in basic health care, giving priority to measures low cost and effective high adhesion power.